Fig. 1.
The opposite effects of NO and ET-1 on vascular function are counterbalanced in healthy tissue and dysregulated in atherosclerosis.
A new mechanism of regulation is the ability of ET-1 in vascular endothelial cells and macrophages to induce arginase expression, which then competes for l-arginine substrate with NO synthase, thereby reducing NO bioavailability.